Skip Map

Number of adults (20–79 years) with diabetes in South Africa (ZA)

2000 886.4 thousand
2011 1.9 million
2024 2.3 million
2050 3.9 million

South Africa is one of the 49 countries and territories in the IDF Africa Region. South Africa has the fourth highest number of adults (20-79 years) with diabetes in the Region.

Data source(s) used for the diabetes estimates in adults:

  1. Mutyambizi, C., Chola, L et al. BMC Public Health. 2017 Sep 26;17(1):745. doi: 10.1186/s12889-017-4792-8. PMID:28950847.
  2. Sahar Sidahmed, Siegfried Geyer, Johannes Beller. BMC Public Health. 2023 Feb 14;23(1):324. doi: 10.1186/s12889-023-15186-w. PMID:36788553.
  3. F. Soriguer, A. Goday, A. Bosch-Comas, E. et al. Int J Public Health. 2022 Aug 16:67:1605072. doi: 10.3389/ijph.2022.1605072. eCollection 2022. PMID: 36051505

People with diabetes, in 1,000s

Compare countries:

Skip Graph

Age-standardised prevalence of diabetes, %

Compare countries:

Skip Chart

At a glance

South Africa

Select a country to compare with:

Clear filter
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s 886.4 1,946.6 2,324.2 3,941.0
Age-standardised prevalence of diabetes, % - 7.0 7.2 8.6
Proportion of people with undiagnosed diabetes, % - - 70.3 -
People with undiagnosed diabetes, in 1,000s - - 1,634.0 -
Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s - - 1,602.5 2,365.8
Age-standardised prevalence of IFG, % - - 4.2 4.7
Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s - 2,113.1 3,048.1 4,895.4
Age-standardised prevalence of IGT, % - 7.8 9.0 10.3
Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes - 47,745.0 24,797.9 -
Proportion of diabetes-related deaths in people 20-79 y, % - - 5.4 -
Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP - - 132,469.7 -
Prevalence of gestational diabetes mellitus (GDM), % - - 11.5 -
Live births affected by other types of diabetes first detected in pregnancy - - 16,420.4 -
Live births affected by other types of diabetes detected prior to pregnancy - - 6,936.2 -
Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million - - 4,599.5 6,308.8
Total diabetes-related health expenditure, ID million - - 9,876.4 13,546.9
Diabetes-related health expenditure per person, USD - 695.0 1,978.9 1,600.8
Diabetes-related health expenditure per person, ID - - 4,249.3 3,437.4
Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups) - - 30,629.0 -
People with type 1 diabetes (0-19 y) - - 4,728.1 -
Demographics
Total adult population (20-79 y), in 1,000s 21,932.0 30,111.8 38,034.2 50,544.8
Population of children and adolescents (0-19 y) - - 21,923,641.5 -
Loading...
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s 886.4
Age-standardised prevalence of diabetes, % -
Proportion of people with undiagnosed diabetes, % -
People with undiagnosed diabetes, in 1,000s -
Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s -
Age-standardised prevalence of IFG, % -
Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s -
Age-standardised prevalence of IGT, % -
Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes -
Proportion of diabetes-related deaths in people 20-79 y, % -
Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP -
Prevalence of gestational diabetes mellitus (GDM), % -
Live births affected by other types of diabetes first detected in pregnancy -
Live births affected by other types of diabetes detected prior to pregnancy -
Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million -
Total diabetes-related health expenditure, ID million -
Diabetes-related health expenditure per person, USD -
Diabetes-related health expenditure per person, ID -
Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups) -
People with type 1 diabetes (0-19 y) -
Demographics
Total adult population (20-79 y), in 1,000s 21,932.0
Population of children and adolescents (0-19 y) -